These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8100483

  • 1. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance.
    Kang Y, Perry RR.
    Cancer Res; 1993 Jul 01; 53(13):3040-5. PubMed ID: 8100483
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen circumvents the multidrug resistance in fresh human gastrointestinal cancer cells.
    Hotta T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tsunoda T, Tamai M, Noguchi K, Mizobata S, Arii K, Terasawa H.
    J Surg Res; 1996 Nov 01; 66(1):31-5. PubMed ID: 8954828
    [Abstract] [Full Text] [Related]

  • 3. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
    Scala S, Pacelli R, Iaffaioli RV, Normanno N, Pepe S, Frasci G, Genua G, Tsuruo T, Tagliaferri P, Bianco AR.
    Cancer Res; 1991 Sep 15; 51(18):4898-902. PubMed ID: 1893380
    [Abstract] [Full Text] [Related]

  • 4. Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance.
    Kang Y, Perry RR.
    Cancer Res; 1994 Jun 01; 54(11):2952-8. PubMed ID: 7910518
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R, Boroujerdi M.
    Cancer Chemother Pharmacol; 2005 Nov 01; 56(5):497-509. PubMed ID: 15937726
    [Abstract] [Full Text] [Related]

  • 6. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J.
    Anticancer Res; 1993 Nov 01; 13(5A):1425-30. PubMed ID: 7902062
    [Abstract] [Full Text] [Related]

  • 7. Interaction between radiation and drug damage in mammalian cells. VI. Radiation and doxorubicin age-response function of doxorubicin-sensitive and -resistant Chinese hamster cells.
    Zhang Y, Sweet KM, Sognier MA, Belli JA.
    Radiat Res; 1992 Oct 01; 132(1):105-11. PubMed ID: 1410265
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
    Slovak ML, Hoeltge GA, Dalton WS, Trent JM.
    Cancer Res; 1988 May 15; 48(10):2793-7. PubMed ID: 2896069
    [Abstract] [Full Text] [Related]

  • 9. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells.
    Venne A, Li S, Mandeville R, Kabanov A, Alakhov V.
    Cancer Res; 1996 Aug 15; 56(16):3626-9. PubMed ID: 8705995
    [Abstract] [Full Text] [Related]

  • 10. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.
    He QY, Jiang B, Zhang HQ, Xue SB.
    Zhongguo Yao Li Xue Bao; 1992 Sep 15; 13(5):416-9. PubMed ID: 1300043
    [Abstract] [Full Text] [Related]

  • 11. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T, Lübbert M, Martens C, Bross KJ, Fiebig HH, Mertelsmann R, Herrmann F.
    Cytokines Mol Ther; 1995 Jun 15; 1(2):123-32. PubMed ID: 9384669
    [Abstract] [Full Text] [Related]

  • 12. Reversal of multidrug resistance by verapamil and modulation by alpha 1-acid glycoprotein in wild-type and multidrug-resistant Chinese hamster ovary cell lines.
    Chatterjee M, Robson CN, Harris AL.
    Cancer Res; 1990 May 01; 50(9):2818-22. PubMed ID: 1970277
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I, Yin MB, Mazzoni A, Abdellah AJ, Rustum YM.
    Anticancer Res; 1989 May 01; 9(3):567-74. PubMed ID: 2764503
    [Abstract] [Full Text] [Related]

  • 14. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 01; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 15. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 16. Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
    Kurebayashi J, Nukatsuka M, Nagase H, Nomura T, Hirono M, Yamamoto Y, Sugimoto Y, Oka T, Sonoo H.
    Cancer Chemother Pharmacol; 2007 Mar 01; 59(4):515-25. PubMed ID: 16900372
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
    Chambers SK, Hait WN, Kacinski BM, Keyes SR, Handschumacher RE.
    Cancer Res; 1989 Nov 15; 49(22):6275-9. PubMed ID: 2804973
    [Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of putative intrinsic multidrug resistant Chinese hamster ovary cells by fluorescence activated cell sorting.
    Zou CP, Van NT, Kuo MT.
    Anticancer Res; 1992 Nov 15; 12(2):427-32. PubMed ID: 1349795
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of P-glycoprotein and increasing of drug-sensitivity of a human carcinoma cell line (KB-A-1) by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro.
    Ren Y, Wei D, Zhan X.
    Biotechnol Appl Biochem; 2005 Apr 15; 41(Pt 2):137-43. PubMed ID: 15202936
    [Abstract] [Full Text] [Related]

  • 20. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
    Azab SS, El-Demerdash E, Abdel-Naim AB, Youssef E, El-Sharkawy N, Osman AM.
    Biochem Pharmacol; 2005 Sep 01; 70(5):725-32. PubMed ID: 16005435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.